These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9371004)

  • 21. [Hormone replacement therapy and venous thromboembolism].
    Trillot N; Susen S; Jude B
    Gynecol Obstet Fertil; 2004 Sep; 32(9):725-8. PubMed ID: 15380753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health risks after cessation of postmenopausal hormone therapy.
    Pines A; Sturdee D; Birkhäuser M;
    Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782
    [No Abstract]   [Full Text] [Related]  

  • 23. [Conventional hormonal replacement therapy in treatment of osteoporosis].
    Meczekalski B; Czyzyk A
    Pol Merkur Lekarski; 2009 Jul; 27(157):72-6. PubMed ID: 19650436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The hormone replacement therapy conundrum.
    Abushama MD; Ahmed BI
    Saudi Med J; 2003 Mar; 24(3):243-4. PubMed ID: 12704496
    [No Abstract]   [Full Text] [Related]  

  • 25. Thrombophilic profile of climacteric and menopausal women with venous thromboembolism.
    Margarido PF; D'Amico E; Bagnoli VR; Fonseca AM; Halbe HW; Pinotti JA
    Climacteric; 2002 Mar; 5(1):87-9. PubMed ID: 11974563
    [No Abstract]   [Full Text] [Related]  

  • 26. Hormone replacement therapy and surveillance considerations.
    Brood-van Zanten MM; Barentsen R; van der Mooren MJ
    Maturitas; 2002 Aug; 43 Suppl 1():S57-67. PubMed ID: 12361889
    [No Abstract]   [Full Text] [Related]  

  • 27. A comparative review of the risks and benefits of hormone replacement therapy regimens.
    Warren MP
    Am J Obstet Gynecol; 2004 Apr; 190(4):1141-67. PubMed ID: 15118656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The risk of getting breast cancer after hormonal replacement therapy for menopause is stopped].
    Jamin C; Madelenat P
    Gynecol Obstet Fertil; 2008 Nov; 36(11):1067-9. PubMed ID: 18951058
    [No Abstract]   [Full Text] [Related]  

  • 29. Few Alternatives As HRT 'Fountain of Youth' Runs Dry.
    Schultz J
    J Natl Cancer Inst; 2004 Aug; 96(16):1202-3. PubMed ID: 15316054
    [No Abstract]   [Full Text] [Related]  

  • 30. Progestins and recurrence in breast cancer survivors.
    Chlebowski RT; Anderson GL
    J Natl Cancer Inst; 2005 Apr; 97(7):471-2. PubMed ID: 15812065
    [No Abstract]   [Full Text] [Related]  

  • 31. [Present status concerning hormone replacement therapy in menopause and the risk of breast cancer].
    Lopes P
    J Gynecol Obstet Biol Reprod (Paris); 1998 Oct; 27(1 Suppl):12-6. PubMed ID: 9864684
    [No Abstract]   [Full Text] [Related]  

  • 32. [Estrogens and progestins in hormone replacement therapy in menopause].
    La Vecchia C
    Recenti Prog Med; 2001 Mar; 92(3):209-12. PubMed ID: 11320854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Controversy between estrogen replacement therapy and risk of breast cancer in menopause].
    Zárate A
    Gac Med Mex; 2002; 138(1):105-7. PubMed ID: 11885123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology and risk factors of venous thromboembolism.
    Ageno W; Squizzato A; Garcia D; Imberti D
    Semin Thromb Hemost; 2006 Oct; 32(7):651-8. PubMed ID: 17024592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
    Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hormonal replacement therapy in menopause and cancer risk. An update].
    La Vecchia C; Franceschi S
    Minerva Ginecol; 2003 Jun; 55(3):217-9. PubMed ID: 14581867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practical strategies for hormone replacement therapy and risk of venous thromboembolism.
    Greer IA
    Br J Obstet Gynaecol; 1998 Apr; 105(4):376-9. PubMed ID: 9609259
    [No Abstract]   [Full Text] [Related]  

  • 38. Estrogen-progestogen replacement therapy and ovarian cancer: an update.
    La Vecchia C
    Eur J Cancer Prev; 2006 Dec; 15(6):490-2. PubMed ID: 17106327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone replacement therapy in menopause and lung cancer: an update.
    La Vecchia C
    Eur J Cancer Prev; 2006 Jun; 15(3):189-90. PubMed ID: 16679859
    [No Abstract]   [Full Text] [Related]  

  • 40. [New SBU-report on estrogen replacement therapy in climacteric. Moderate risk of breast cancer after long-term use].
    Lakartidningen; 2002 Jul; 99(28-29):3031-4. PubMed ID: 12170514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.